Investors may doubt the company's ability to improve sluggish revenue, despite a superior outlook. Market hesitation could be due to priced-in risks, though a share price plunge seems unlikely given high growth forecasts.
Gainers: In reaction to earnings/guidance: •$欧迪办公(ODP.US)$+8.03% (The ODP Corporation gains on guiding Q2 and FY22 earnings above the consensus; to buyback shares of $600M) •$Synchrony Financial(SYF.US)$+4.2%(The financial services company posted adjusted earnings per share of $1.60 for the June ended quarter, beating analysts' estimates of $1.41 per share, according to FactSet.) •$高盛(GS.US)$+4.2% (Goldman Sachs beats...
Gainers: •$Kezar Life Sciences(KZR.US)$+92% (announces positive top line results from the MISSION Phase 2 trial) •$Sutro Biopharma(STRO.US)$+24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates) •$Ceragon(CRNT.US)$+17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh) •$携程网(TCOM.US)$+15.6% (In reaction to earnings/guidance) •$Apyx Medical(APYX.US)$+8% (anno...
$Apyx Medical(APYX.US)$ - Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction. Breaking above $6. Next level to break is $7 $BlackSky Technology(BKSY.US)$ - BlackSky Wins 10-Year Electro Optical Commercial Layer Contract With US Gov't.,Stock needs to break $3 to continue higher $佳益净科控股(JCSE.US)$ - Stock recent runner breaking higher. Back above IPO price. Adding above $15.50 $诺德斯特龙(JWN.US)$ - CO...
2
2
举报
RWJY CCJM :
Just curious, will it fly after $3 for BKSY
JESSE JAMES8832楼主 : bottom watch
zainong : How come ah